Dr. Jeffrey Gladden explains why blood tests alone aren't enough for hormone replacement therapy. Without looking at genetics, biochemical pathways, and metabolites together, patients risk hormone-related cancers like breast, prostate, and endometrial cancer. Safe HRT requires a full systems approach.
It is a complex thing to replace estrogen and progesterone, right? And DHEA and other things that are commonly used. It is a complex equation. It's not just looking at the blood levels. And you can expose yourself to significant risk of cancer, either prostate, breast cancer, endometrial cancer, et cetera, if you're not looking at this from a systems approach where you're looking at all the different pieces and doing it from the genetics up through the biochemical levels of these different hormones and their metabolites.
